They Just Don't Get...
Health Care: Health Services
Baxter International Inc. (BAX: NYSE)
$50.06 -0.11 | -0.22%
06/04/12 - 04:01 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 13.89B | 12.84B | 12.56B | 12.35B |
| Cost of Sales | 6.18B | 6.20B | 5.40B | 5.59B |
| Gross Operating Profit | 7.72B | 6.64B | 7.16B | 6.76B |
| Selling, General, and Administrative Expenses | 3.15B | 2.91B | 2.73B | 2.70B |
| Research & Development | 946.00M | 915.00M | 917.00M | 868.00M |
| Operating Income before D & A (EBITDA) | 3.62B | 2.82B | 3.52B | 3.20B |
| Depreciation & Amortization | 670.00M | 685.00M | 638.00M | 631.00M |
| Interest Income | 38.00M | 28.00M | 19.00M | 72.00M |
| Other Income - Net | -83.00M | -147.00M | -33.00M | -12.00M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 2.90B | 2.00B | 2.85B | 2.60B |
| Interest Expense | 92.00M | 115.00M | 117.00M | 148.00M |
| Pre-Tax Income | 2.81B | 1.89B | 2.73B | 2.45B |
| Income Taxes | 553.00M | 463.00M | 519.00M | 437.00M |
| Minority Interest | 32.00M | 7.00M | 10.00M | 0.00 |
| Net Income From Continuing Operations | 2.22B | 1.42B | 2.20B | 2.01B |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 2.22B | 1.42B | 2.20B | 2.01B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 2.22B | 1.42B | 2.20B | 2.01B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.22B | 1.42B | 2.20B | 2.01B |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 2.22B | 1.42B | 2.20B | 2.01B |
| Basic EPS from Continuing Ops. | 3.91 | 2.41 | 3.63 | 3.22 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 3.91 | 2.41 | 3.63 | 3.22 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 3.91 | 2.41 | 3.63 | 3.22 |
| Basic Normalized Net Income/Share | 3.91 | 2.41 | 3.63 | 3.22 |
| EPS fr Continuing Ops. | 3.88 | 2.39 | 3.59 | 3.16 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 3.88 | 2.39 | 3.59 | 3.16 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 3.88 | 2.39 | 3.59 | 3.16 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
3.88 | 2.39 | 3.59 | 3.16 |
| Dividends Paid per Share | 1.27 | 1.18 | 1.07 | 0.91 |
Portfolios with BAX
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorMost-Searched Stocks for th...
- ContributorTop-Yielding Health Service...
- ProBill Frels - Mairs & Power
- ProHighbridge Capital Management
- ProFarallon Capital Management
- UserDividend Income 2011-11-23
- ProJohn Buckingham - Al Frank ...
- ContributorDividend Stocks for the Wee...
- Contributor9 Stocks With Low Volatilit...
Latest BAX Headlines from TheStreet
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.25.12 | 05:05 pm
- 6 Low-Yield Dividend Captures 05.18.12 | 11:05 am
- Baxter International Inc. (BAX): Today's Featured Health Services Loser 05.11.12 | 04:05 pm
- 'Mad Money' Lightning Round: Devon's Worth More 04.19.12 | 07:04 pm
- Baxter International's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 02:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 06:04 pm
- Mattel, Endocyte, Ivanhoe Are Market Movers 04.16.12 | 05:04 pm
- 7 Hot Stocks on Traders' Radars 04.16.12 | 03:04 pm
- NYSE Stocks Posting Largest Percentage Decreases 04.16.12 | 01:04 pm
- 'Mad Money' Lightning Round: Bullish on Baxter 03.27.12 | 07:03 pm
Press Releases for BAX
- Baxter Announces Collaboration With Chatham Therapeutics For Factor IX Hemophilia B Gene Therapy Treatment - Business Wire 06.04.12 | 09:06 am
- Baxter To Present At William Blair & Company 32nd Annual Growth Stock Conference - Business Wire 05.30.12 | 04:05 pm
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control In Trials Of Diabetics Undergoing Dialysis - Business Wire 05.25.12 | 03:05 am
- Baxter To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - Business Wire 05.23.12 | 04:05 pm
- Baxter Announces ADVATE Approval In China For The Treatment Of Hemophilia A - Business Wire 05.16.12 | 09:05 am
- Baxter Declares Quarterly Dividend - Business Wire 05.07.12 | 04:05 pm
- Baxter To Present At Bank Of America Merrill Lynch 2012 Healthcare Conference - Business Wire 05.02.12 | 04:05 pm
- Leading Health Economist Mark V. Pauly, Ph.D., Named 2012 Recipient Of The Willam B. Graham Prize For Health Services Research - Business Wire 05.01.12 | 09:05 am
- Baxter Completes Purchase Of Sigma International - Business Wire 04.26.12 | 08:04 am
- Baxter To Present At Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference - Business Wire 04.24.12 | 04:04 pm
Partner Headlines for BAX
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- Stock Analysts Upgraded or Downgraded These Shares on Jun 1st - Wall St. Cheat Sheet 06.01.12 | 04:06 am
- UPDATE: Citi Lowers Baxter's PT - Benzinga 04.20.12 | 09:04 am
- Notable Options Activity in BAX - Benzinga 04.16.12 | 01:04 pm
- Baxter International Inc.: Worth A Look - Seeking Alpha 03.12.12 | 09:03 am
- Haemonetics Reaffirmed at Neutral - Analyst Blog - Zacks 03.02.12 | 06:03 pm
- Boston Scientific Offers Investors Huge Valuation Upside - Seeking Alpha 02.29.12 | 09:02 am
- Significant Upside Of About 25% For Baxter, Covidien - Seeking Alpha 02.24.12 | 05:02 pm
- Mylan Looks To Reap A Harvest Of Patent Expirations - Seeking Alpha 02.22.12 | 09:02 am
- Building A Capital Preservation And Income Portfolio, Part 8 - Seeking Alpha 02.17.12 | 04:02 pm
